D. E. Shaw & Co., Inc. Xencor Inc Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Xencor Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 49,164 shares of XNCR stock, worth $930,674. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,164

Previous 38,582 27.43%

Holding current value

$930,674

Previous $819,000 32.72%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $197,354 - $280,634	10,582 Added 27.43%	49,164 $1.09 Million
Q4 2023 Feb 14, 2024	SELL	$16.53 - $21.42 $472,427 - $612,183	-28,580 Reduced 42.55%	38,582 $819,000
Q3 2023 Nov 14, 2023	BUY	$20.08 - $25.39 $923,539 - $1.17 Million	45,993 Added 217.27%	67,162 $1.35 Million
Q2 2023 Aug 14, 2023	BUY	$24.77 - $29.9 $115,849 - $139,842	4,677 Added 28.36%	21,169 $528,000
Q1 2023 May 15, 2023	SELL	$25.95 - $36.95 $57,557 - $81,955	-2,218 Reduced 11.85%	16,492 $459,000

Q4 2022 Feb 14, 2023	SELL	$24.79 - $30.86 $180,074 - $224,167	-7,264 Reduced 27.97%	18,710 $487,000
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $355,512 - $468,433	-14,440 Reduced 35.73%	25,974 $675,000
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $451,157 - $663,023	22,855 Added 130.16%	40,414 $1.11 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $468,474 - $730,981	17,559 New	17,559 $468,000
Q4 2021 Feb 14, 2022	SELL	$33.67 - $43.44 $897,978 - $1.16 Million	-26,670 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $581,307 - $676,706	-18,966 Reduced 41.56%	26,670 $871,000
Q2 2021 Aug 16, 2021	BUY	$34.33 - $44.68 $426,618 - $555,238	12,427 Added 37.42%	45,636 $1.57 Million
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $1.36 Million - $1.79 Million	33,209 New	33,209 $1.43 Million
Q3 2020 Nov 16, 2020	SELL	$30.09 - $43.02 $2.09 Million - $2.99 Million	-69,470 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.76 - $33.42 $1.24 Million - $1.49 Million	44,535 Added 178.6%	69,470 $2.25 Million
Q1 2020 May 15, 2020	BUY	$20.69 - $37.79 $515,905 - $942,293	24,935 New	24,935 $745,000
Q3 2019 Nov 14, 2019	SELL	$33.73 - $46.27 $189,225 - $259,574	-5,610 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$29.6 - $40.93 $220,401 - $304,764	-7,446 Reduced 57.03%	5,610 $230,000
Q1 2019 May 15, 2019	SELL	$27.85 - $38.09 $1.79 Million - $2.45 Million	-64,229 Reduced 83.11%	13,056 $406,000
Q4 2018 Feb 14, 2019	BUY	$32.39 - $42.05 $1.09 Million - $1.42 Million	33,765 Added 77.59%	77,285 $2.8 Million
Q3 2018 Nov 14, 2018	BUY	$35.69 - $47.65 $975,050 - $1.3 Million	27,320 Added 168.64%	43,520 $1.7 Million
Q2 2018 Aug 14, 2018	SELL	$28.41 - $42.41 $217,677 - $324,945	-7,662 Reduced 32.11%	16,200 $600,000
Q1 2018 May 15, 2018	SELL	$21.18 - $33.78 $360,949 - $575,678	-17,042 Reduced 41.66%	23,862 $715,000
Q4 2017 Feb 14, 2018	SELL	$19.29 - $24.83 $966,583 - $1.24 Million	-50,108 Reduced 55.06%	40,904 $897,000
Q3 2017 Nov 14, 2017	BUY	$19.61 - $23.35 $1.78 Million - $2.13 Million	91,012	91,012 $2.09 Million

Others Institutions Holding XNCR

# of Institutions

203

Shares Held

64M

Call Options Held

2.2K

Put Options Held

1.3K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.13B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account